June Monthly Fiscal Highlights for the State of Arizona
Republished with permission from Senator John McComish, Representative Bob Robson and Representative Jeff Dial (Legislative District 20)Continue reading
The Central Contractor Registry (CCR) as well as the Online Representations and Certifications Application (ORCA) web sites and facilities have given way to the federal government’s new omnibus system, the System for Award Management (SAM).Continue reading
Each Sunday, BioCentury This Week focuses on key issues in the bioindustry. On Sunday July 22, 2012, the focus of the program zeroed in on the recent news from Washington on the FDA Investigation regarding “whistle blowers” and the protection of industry confidential information.Continue reading
After a long and collaborative effort between the FDA and Industry, the Food and Drug Administration Safety and Innovation Act (FDASIA) including reauthorization of MDUFA and PDUFA head to the White House for signature into law. Continue reading
A Washington Update for AZBio Members.Continue reading
As industry leaders we all need to stay in the loop on key issues that affect our industry and our state. One of those issues is the 2.3% Medical Device Tax. When we were out in DC last April, AZBio leadership met with all of our Congressional teams to share information on how this tax impacts our industry and our state . In addition to sharing with them what is happening here in Arizona, we asked them if they would keep us “in the loop” on what is happening at our nation’s capitol.
On Thursday, June 7, 2012 we got some important news from Capitol Hill.
Read on for a special “In the Loop” guest post by Congressman Paul Gosar, R-AZContinue reading